You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 129 No. 7, July 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (14)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Oncology
 •Head & Neck Cancer
 •Neoplasms of Head & Neck
 •Salivary Gland Disorders
 •Alert me on articles by topic

High Incidence of Lymph Node Metastasis in Major Salivary Gland Cancer

Eberhard Stennert, MD; Dilek Kisner; Markus Jungehuelsing, MD; Orlando Guntinas-Lichius, MD; Ursula Schröder, MD; Hans Edmund Eckel, MD; Jens Peter Klussmann, MD

Arch Otolaryngol Head Neck Surg. 2003;129:720-723.

Objective  To analyze the incidence and risk factors for clinically apparent and occult lymph node metastases in patients with major salivary gland cancers.

Design  Cohort of patients with a median follow-up of 46 months (range, 1-174 months).

Setting  University-based referral center.

Patients  A total of 160 consecutive patients with complete clinical and pathologic data.

Intervention  Neck dissection was performed in all cases. Patients were treated with surgery alone (55%); surgery and radiation therapy (43%); or a combination of surgery, radiation, and chemotherapy (2%).

Main Outcome Measure  Incidence of apparent and occult lymph node metastases. Univariate and multivariate analyses were used to evaluate the significance of clinical and pathologic data.

Results  Histologically confirmed positive neck was found in 53% of all cases. Histologic diagnosis was significantly related to the incidence of lymph node metastasis: 89% (16/18) for undifferentiated carcinomas. However, so-called low-risk tumors had incidence rates of 22% to 47%. Twenty-one patients (13%) presented with clinically apparent cervical lymph node metastasis. Of the 139 patients with clinical N0 neck, 45% had occult neck metastasis. Neck metastasis was found in 29% (10/34) of T1, 54% (38/70) of T2, 65% (20/31) of T3, and 54% (16/25) of T4 tumors. Assessment of survival according to nodal status revealed significant correlations for overall (P<.001) and disease-free survival (P<.001).

Conclusions  We found a high incidence of lymph node metastasis from major salivary gland cancers. Neck dissections should be considered as an integral part of the surgical approach in patients with major salivary gland cancer, especially if no postoperative radiation therapy is planned.


From the Department of Oto-Rhino-Laryngology, Head and Neck Surgery, University of Cologne, Cologne, Germany (Drs Stennert, Guntinas-Lichius, Schröder, and Klussmann and Ms Kisner); Department of Oto-Rhino-Laryngology, Klinikum Ernst von Bergmann, Potsdam, Germany (Dr Jungehuelsing); and Department of Oto-Rhino-Laryngology, Klagenfurt General Hospital, Klagenfurt, Austria (Dr Eckel). The authors have no relevant financial interest in this article.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.